Cost-effectiveness analysis of donepezil and rivastigmine for mild to moderate Alzheimer's disease in Taiwan
May 1, 2013, 00:00
10.1016/j.jval.2013.03.493
https://www.valueinhealthjournal.com/article/S1098-3015(13)00564-0/fulltext
Title :
Cost-effectiveness analysis of donepezil and rivastigmine for mild to moderate Alzheimer's disease in Taiwan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00564-0&doi=10.1016/j.jval.2013.03.493
First page :
A104
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
32